Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2024
A Review of the Clinical Introduction of 4D Particle Therapy Research Concepts, Barbara Knäusl, Gabriele Belotti, Jenny Bertholet, et al.
Phase 1/2 Trial of Avelumab Combined With Utomilumab (4–1BB Agonist), Pf-04518600 (OX40 Agonist), or Radiotherapy in Patients With Advanced Gynecologic Malignancies, Anne Knisely, Jibran Ahmed, Bettzy Stephen, et al.
Phase 1b Study of Intraperitoneal Ipilimumab and Nivolumab in Patients With Recurrent Gynecologic Malignancies With Peritoneal Carcinomatosis, Anne Knisely, Emily Hinchcliff, Bryan Fellman, et al.
Phase 1b Study of Batiraxcept in Combination With Durvalumab in Patients With Platinum-Resistant Ovarian Cancer, Anne Knisely, Emily M Hinchcliff, Elisabeth Gardiner, et al.
Racial and Sociodemographic Disparities in the Use of Targeted Therapies in Advanced Ovarian Cancer Patients With Medicare, Anne Knisely, Chi-Fang Wu, Alexa Kanbergs, et al.
Chronic Lymphocytic Leukemia: Disease Biology, Stefan Koehrer and Jan A Burger
Inter-Individual Variations in Circadian Misalignment-Induced NAFLD Pathophysiology in Mice, Nobuya Koike, Yasuhiro Umemura, Hitoshi Inokawa, et al.
Resin-Based 90 Y Tumor Dose as a Predictor of Duration of Response and Survival in Patients With Surgically Unresectable Hepatocellular Carcinoma : A Prospective Single-Arm Study, Nima Kokabi, Linzi A Webster, Howard Dabbous, et al.
Tumor Niche Network-Defined Subtypes Predict Immunotherapy Response of Esophageal Squamous Cell Cancer, Kyung-Pil Ko, Shengzhe Zhang, Yuanjian Huang, et al.
Experience With a Hybrid Recruitment Approach of Patient-Facing Web Portal Screening and Subsequent Phone and Medical Record Review for a Neurosurgical Intervention Trial for Chronic Ischemic Stroke Disability (Pisces III), Brad J Kolls, Keith W Muir, Sean I Savitz, et al.
Immune Checkpoint Blockade Resistance in Lung Cancer: Emerging Mechanisms and Therapeutic Opportunities, Jessica M Konen, Haoyi Wu, and Don L Gibbons
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial, Marina Y Konopleva, Monique Dail, Naval G Daver, et al.
Disease Progression, Survival, and Molecular Disparities in Black and White Patients With Endometrioid Endometrial Carcinoma in Real-World Registries and GOG/NRG Oncology Randomized Phase III Clinical Trials, Zachary A Kopelman, Chunqiao Tian, Jordyn Tumas, et al.
Molecular Profiling of Braf-V600E-Mutant Metastatic Colorectal Cancer in the Phase 3 Beacon CRC Trial, Scott Kopetz, Danielle A Murphy, Jie Pu, et al.
Harnessing microRNA-Enriched Extracellular Vesicles for Liquid Biopsy, Song Yi Ko, WonJae Lee, and Honami Naora
Enhancer Reprogramming Underlies Therapeutic Utility of a SMARCA2 Degrader in SMARCA4 Mutant Cancer, Sasikumar Kotagiri, Nicholas Blazanin, Yuanxin Xi, et al.
Longitudinal Changes in the Carotid Arteries of Head and Neck Cancer Patients Following Radiation Therapy: Results From a Prospective Serial Imaging Biomarker Characterization Study, Efstratios Koutroumpakis, Abdallah Sherif Radwan Mohamed, Peter Chaftari, et al.
Leptin Levels Are Associated With Coronary Artery Calcification in Patients With Advanced Prostate Cancer, Efstratios Koutroumpakis, Neha Venkatesh, Ana Aparicio, et al.
Management of Incomplete Microcirculatory Reperfusion After Endovascular Thrombectomy: Focus on Inhibition of the Glycoprotein IIb/IIIa Receptor Pathway, Neeharika Krothapalli, Thomas Ortel, Devin McBride, et al.
USP22 Overexpression Fails to Augment Tumor Formatiaon in MMTV-ERBB2 Mice but Loss of Function Impacts Mmtv Promoter Activity, Xianghong Kuang, Andrew Salinger, Fernando Benavides, et al.
USP22 Overexpression Fails to Augment Tumor Formation in MMTV-ERBB2 Mice but Loss of Function Impacts MMTV Promoter Activity, Xianghong Kuang, Andrew Salinger, Fernando Benavides, et al.
USP22 Overexpression Fails To Augment Tumor Formation in MMTV-ERBB2 Mice but Loss of Function Impacts MMTV Promoter Activity, Xianghong Kuang, Andrew Salinger, Fernando Benavides, et al.
Sotorasib With Panitumumab in Chemotherapy-Refractory KRAS G12C-Mutated Colorectal Cancer: A Phase 1b Trial, Yasutoshi Kuboki, Marwan Fakih, John Strickler, et al.
Survival Disparities in Non-Hispanic Black and White Cervical Cancer Patients Vary by Histology and Are Largely Explained by Modifiable Factors, Calen W Kucera, Nicole P Chappell, Chunqiao Tian, et al.
Batf Is a Major Driver of Nk Cell Epigenetic Reprogramming and Dysfunction in AML, Bijender Kumar, Anand Singh, Rafet Basar, et al.